Status:
RECRUITING
Neurorehabilitation Through Hippotherapy of a Brain Stroke
Lead Sponsor:
Alliance Equiphoria
Collaborating Sponsors:
Boehringer Ingelheim
Centre Hospitalier Sud Francilien
Conditions:
Cerebrovascular Accident
Neurorehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cerebrovascular accident \[CVA\] (medical term for stroke) is a high burden worldwide disorder and the second leading cause of disability. As illustrated by the number of survivors that remain disable...
Detailed Description
According to the WHO (2016), almost 1.1 million of Europeans suffer a stroke each year (17 million worldwide), which adds to a pool of 33 million stroke survivors. The case fatality rates are about 15...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Ischemic or haemorrhagic stroke according to ICD 10 I61-I69 (30)
- Inclusion \> 3 months post-stroke
- Deficit still existing (Rankin score ≥ 3 and ≤ 4 at inclusion)
- Existing declaration of informed consent
- Affiliation of the patient to a social security scheme
- Minimal abduction of the hip of 25 degrees bilateral with no history of hip dislocation and/or dysplasia
- Certificate of non-contraindication issued by the referring physician
Exclusion
- Major cognitive impairment affecting comprehension (Mini Mental State Examination test \< 24 points)
- Global or sensory aphasia
- Neurological or psychiatric co-morbidity (other than mild-to-moderate post-stroke depression)
- Evidence of an uncontrolled seizure disorder
- Substance abuse
- History of uncontrolled pain
- History of allergic reactions to dust and/or horsehair, or severe asthma
- Overweight (≥ 110 kg)
- Contraindications to physical activity
- Inability or medical contraindication to travel to the Equiphoria Institute by personal car or taxi
- History of horse riding or hippotherapy care during the last 6 months
- Pregnant or lactating women
- Patients participating in other biomedical research or in a period of exclusion
Key Trial Info
Start Date :
April 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04759326
Start Date
April 27 2022
End Date
March 1 2026
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Equiphoria
La Canourgue, France, 48500